# Chapter 13. Ancient Mobile Elements, Viral Relics, and RNA-Linked Genome Innovation

## Scope Note

This chapter explains how RNA-linked mobile elements, viral relics, and genome defense systems have shaped genomes and supplied reusable molecular machinery. The central objects are group I introns, group II introns, retrotransposons, reverse transcriptases, telomerase ribonucleoproteins, viral RNA genomes, endogenous viral elements, CRISPR RNAs, transposon-associated RNA-guided nucleases, CRISPR-associated transposons, and defense-associated reverse transcriptases. These systems are not side stories in RNA evolution. They show how RNA catalysis, RNA-templated DNA synthesis, RNA-guided targeting, and host genome defense can become sources of new genome architecture, new regulatory material, and new biotechnology.

The chapter is conservative about deep evolutionary reconstruction. A modern group II intron, LINE retrotransposon, telomerase particle, RNA virus, or CRISPR-associated transposon is not a pristine fossil from the RNA world. Modern systems have been reshaped by mutation, recombination, host selection, genetic conflict, horizontal transfer, and molecular domestication. The useful question is therefore not whether a modern element is "ancient" in every detail. The useful question is which biochemical principles, molecular modules, and evolutionary routes connect RNA-linked elements to genome innovation.

[Chapter 12](chapter1011.md) introduced comparative genomics, covariance, and family-evolution logic. [Chapter 13](chapter1012.md) uses those principles to interpret mobile and viral systems. [Chapter 14](chapter1013.md) begins Part 3 by cataloging RNA gene repertoires. [Chapter 16](chapter1015.md) treats repeats and retroelements in greater depth. [Chapter 23](chapter1022.md) treats reverse-transcriptase enzymology, [Chapter 27](chapter1026.md) treats pathway-specific splicing chemistry, and [Chapter 9](chapter1162.md) compares group I and group II introns with other catalytic RNAs. Chapters [82](chapter1077.md), [101](chapter1096.md), and [147](chapter1146.md) return to RNA-guided defense and biotechnology.

## Executive Summary

RNA-linked mobile elements are genetic systems whose movement, replication, or biological effect depends on RNA as a catalyst, template, guide, genome, or regulatory molecule. Group I and group II introns show that RNA molecules can be catalytic genome residents. Group I introns can be mobile when homing endonucleases promote copying into intronless alleles, as shown by classic Chlamydomonas chloroplast intron work and homing-endonuclease mechanism reviews. Group II introns combine self-splicing ribozyme chemistry, lariat formation, intron-encoded protein assistance, maturase activity, and reverse-transcriptase-linked mobility. This combination makes group II introns important bridges among catalytic RNA, retroelements, and spliceosomal intron evolution.

Reverse transcriptase is one of the most important reused enzymes in RNA-linked genome innovation. A reverse transcriptase synthesizes DNA from an RNA template. That chemistry supports retroviruses, retrotransposons, group II introns, telomerase, retrons, defense systems, transcriptomic methods, and genome-engineering tools. In non-LTR retrotransposons such as LINE-like elements, target-primed reverse transcription couples a genomic DNA nick to copying of an element RNA at the insertion site. This is a concrete example of RNA expression being converted into durable DNA sequence change.

Telomerase illustrates domestication rather than ordinary selfish mobility. Telomerase is an RNA-templated reverse transcriptase ribonucleoprotein in which telomerase RNA supplies a repeat template and telomerase reverse transcriptase extends chromosome ends. Telomerase shares reverse-transcriptase logic with retroelements, but its biological role is controlled chromosome-end maintenance. This distinction matters: related chemistry does not imply identical lifestyle, and homology to reverse transcriptases does not by itself specify the exact evolutionary route of telomerase origin.

Viral RNA systems are evolutionary laboratories for replication, population diversity, structured genome control, and host interaction. RNA virus populations often exist as mutant spectra shaped by replication errors, selection, drift, recombination, and bottlenecks rather than as single invariant sequences. Viral RNA genomes can also contain structured regions and long-range interactions that influence replication, translation, packaging, or immune recognition, but structure-function claims require evidence beyond folding prediction. Viral relics in host genomes can become regulatory or structural material, but genomic retention or transcription alone does not prove domestication.

Genome defense systems provide a second route from conflict to innovation. CRISPR-Cas systems established a general engineering principle: a guide RNA can direct a protein effector to a chosen nucleic acid target. More recent examples connect mobile elements with programmable RNA-guided activity, including TnpB-like nucleases from IS200/IS605 transposons, TIGR-Tas systems, CRISPR-associated transposons, and defense-associated reverse transcriptase systems with noncoding RNA involvement.

The chapter's interpretive rule is simple: do not confuse presence with function. A mobile-element sequence, viral fragment, retroelement transcript, or guide-RNA-like locus may be raw material, neutral debris, harmful activity, a silenced relic, or a domesticated host system. Molecular domestication requires evidence for regulated host-retained function, not just sequence similarity, expression, or a plausible story.

## Concept Inventory

- **Mobile ribozyme:** a catalytic RNA element that can remove itself from RNA and, in some systems, spread to another genomic location with protein or DNA-repair assistance. "Mobile" and "ribozyme" describe different properties. A self-splicing intron may catalyze RNA processing without being detectably mobile, and a mobile element may depend mainly on protein machinery rather than RNA catalysis.
- **Group I intron:** a self-splicing intron class that usually uses an external guanosine nucleophile during splicing. Some group I introns carry or associate with homing endonucleases. A homing endonuclease cuts an intronless allele or target sequence, after which repair can copy the intron-containing sequence into that site. The Chlamydomonas chloroplast I-CreI-associated intron provides a classic example where self-splicing, DNA endonuclease activity, and in vivo mobility were examined together, while homing-endonuclease reviews define the DNA-recognition and cleavage logic that drives homing.
- **Group II intron:** a self-splicing intron class that forms a lariat intermediate and often encodes an intron-encoded protein. The intron RNA provides catalytic architecture. The intron-encoded protein can have maturase activity that helps the RNA fold, reverse transcriptase activity that copies intron RNA into DNA during mobility, and sometimes DNA endonuclease activity that helps initiate target insertion. Retrohoming is the group II intron mobility route in which an intron ribonucleoprotein recognizes a DNA target, reverse-splices the intron RNA into DNA, and uses reverse transcription and DNA repair to install the intron.
- **Reverse transcriptase:** an RNA-dependent DNA polymerase. The same enzymatic logic appears in distinct biological contexts: retroviruses use reverse transcriptase during infection; retrotransposons use it during copying; group II introns use it during mobility; telomerase uses it for chromosome-end extension; some defense systems use reverse-transcriptase-linked modules in anti-phage activity; technologies use reverse transcriptase for RNA measurement and genome engineering.
- **Retrotransposon:** a transposable element that moves through an RNA intermediate copied back into DNA. Long terminal repeat retrotransposons, non-LTR LINEs, and nonautonomous SINEs differ in proteins, RNA structures, priming routes, and dependence on other elements. Target-primed reverse transcription is especially associated with non-LTR retrotransposons: a nicked genomic DNA end primes reverse transcription of an element RNA at the insertion site.
- **Telomerase RNA:** the RNA component of telomerase. It provides the template for telomeric repeat synthesis and contributes to ribonucleoprotein assembly. Telomerase reverse transcriptase, or TERT, is the catalytic protein subunit that copies the telomerase RNA template. Telomerase belongs conceptually in this chapter because it uses RNA-templated DNA synthesis, but telomerase is not an ordinary mobile element.
- **Viral quasispecies:** a population of related viral genomes generated by mutation, selection, drift, recombination, and bottlenecks. The term describes population structure and dynamics, not merely any viral variant. An endogenous viral element is a viral-derived sequence retained in a host genome. Endogenous viral elements are often relics, but some can be domesticated. Domestication, also called exaptation or co-option, means evolutionary recruitment of a mobile-element or viral component into a regulated host function.
- **CRISPR RNA:** a guide RNA derived from a CRISPR array that directs Cas effectors to complementary nucleic acid targets. TnpB is a compact transposon-associated RNA-guided endonuclease family related to the evolutionary landscape of programmable nucleases. A CRISPR-associated transposon couples CRISPR-derived targeting logic with DNA insertion machinery. A defense-associated reverse transcriptase is a reverse-transcriptase-linked bacterial defense module, sometimes involving noncoding RNA, whose role is anti-phage defense rather than ordinary retroelement copying.

## What to Know Before Reading This Chapter

The reader should remember several ideas from earlier chapters. First, RNA can carry information, fold into structure, bind proteins, and catalyze reactions. Catalysis depends on folded geometry, reactive groups, metal ions, and cellular context. Second, a ribonucleoprotein is not "RNA plus decoration." In many RNPs, RNA and protein parts form a single functional machine. Third, evolutionary inference depends on evidence. Shared domains, similar reaction chemistry, patchy phylogenetic distribution, and conserved structure are clues, not complete histories.

The chapter also assumes basic genome vocabulary. A transposable element is a genetic element that can move or copy itself within or between genomes. A host genome is the cellular genome in which an element resides. A selfish genetic element is an element whose propagation can be partly independent of host benefit. Selfishness is not a permanent category; host genomes can silence, tolerate, or recruit element-derived material.

Four running examples recur throughout the chapter. Group II introns demonstrate how a catalytic RNA can be linked to protein-assisted mobility. LINE-like retrotransposons show how an RNA intermediate becomes a new DNA insertion. Telomerase shows how reverse-transcriptase chemistry can be domesticated for chromosome-end maintenance. CRISPR-associated and TnpB-like systems show how defense and mobile-element modules can become programmable tools.

The main evidence caution is that mobile-element and viral biology is especially vulnerable to story-like overinterpretation. Sequence similarity may indicate ancestry, but it may also reflect a shared domain, horizontal transfer, contamination, or convergent use of a successful fold. Transcription may indicate activity, but it may also reflect leaky promoters, readthrough, stress, poor mapping, or decay. Engineering utility may reveal a controllable molecular mechanism, but it does not automatically reveal the natural function of the system.

## 13.1. Group I and group II introns as mobile ribozymes

**Table 13.1. Mobile RNA-Linked Element Classes.** Key properties distinguishing major RNA-linked mobile and genome-resident element types, with representative biological consequences and evidence caveats.

| Element or system | Main RNA component | Main protein component | Mobility or target route | Biological consequence | Evidence caveat |
| --- | --- | --- | --- | --- | --- |
| **Group I intron** | Intron RNA (guanosine-dependent splice sites) | Homing endonuclease | Endonuclease cuts intronless allele; repair copies intron in | Spread among rRNA, bacteriophage, and organellar genes | Direct mobility references limited; splicing and mobility are distinct |
| **Group II intron** | Intron RNA lariat (ribozyme) | Intron-encoded protein (maturase + RT) | Retrohoming: reverse-splicing into DNA followed by RT copying | Organellar gene insertion; mechanistic bridge to spliceosomal introns | Active mobility requires protein; splicing activity alone does not imply spread |
| **LINE (non-LTR retrotransposon)** | Element mRNA (encodes ORF1, ORF2) | ORF2 protein (endonuclease + RT) | Target-primed reverse transcription at genomic nick | Genome expansion; gene disruption; new regulatory sequences | Most insertions neutral or silenced; locus-specific mapping needed |
| **LTR retrotransposon** | Genomic RNA flanked by LTRs | Gag-like + RT/integrase-like proteins | Intracellular retroviral-like cycle; integrase-mediated insertion | Repeat expansion; endogenous retroviral sequences; regulatory potential | Often lacks infectious capacity; chromatin silencing common |
| **Telomerase** | Telomerase RNA (template region + assembly domains) | TERT + accessory RNP proteins | Template-directed repeat addition at chromosome 3′ ends | Chromosome-end maintenance; loss causes telomere shortening | Domesticated RT; not an ordinary mobile element |
| **Endogenous viral element** | Viral-derived RNA (when transcribed) | Remnant viral proteins (often degraded) | No active replication; genomic retention from ancient infection | Possible regulatory effects or neutral debris | Transcription or sequence similarity alone does not prove domestication |
| **CRISPR array** | Pre-crRNA processed into crRNA | Cas proteins (e.g., Cas9, Cas12) | Guide RNA directs Cas effector to complementary DNA target | Bacterial adaptive immunity; genome-editing platform | Guide-function claims require experimental validation beyond prediction |
| **TnpB system** | Transposon-associated guide RNA | TnpB compact RNA-guided endonuclease | Guide RNA directs TnpB to target DNA | Mobile element targeting; programmable compact nuclease | Natural target range and in vivo specificity incompletely characterized |
| **CRISPR-associated transposon** | crRNA or guide RNA | Transposase + Cas proteins | RNA-guided DNA integration at guide-specified site | Site-specific DNA insertion; programmable transposition | Primary mechanism and specificity papers still needed |

Group I and group II introns are among the clearest examples of RNA molecules acting as both genetic elements and catalytic machines. An intron is an intervening sequence removed from a precursor RNA. In most textbook examples, introns are discussed as parts of eukaryotic pre-mRNAs processed by the spliceosome. Group I and group II introns broaden that picture. Their RNA folds can catalyze splicing reactions, and some members can spread to new genomic sites.

Group I introns generally splice through a guanosine-dependent pathway. A free guanosine or guanosine nucleotide attacks the 5′ splice site, and subsequent transesterification releases the intron and ligates exons. Many group I introns reside in organellar genomes, bacteriophage genomes, bacterial genomes, or nuclear rRNA genes. Some are associated with homing endonucleases. A homing endonuclease recognizes an intronless allele and cuts the DNA. DNA repair can then copy the intron-containing sequence into the break site, converting an intronless locus into an intron-containing locus.

The boundary case is important. The RNA catalytic reaction and the DNA-level mobility route are separable. A group I intron can be self-splicing without being mobile under observed conditions. A group I intron can also depend on a protein endonuclease for movement rather than moving as pure RNA. The source-backed claim for this chapter is therefore specific: group I introns can link ribozyme self-splicing to homing-endonuclease-mediated DNA mobility, but target recognition, endonuclease-family diversity, host repair, and homing kinetics must be stated for the particular intron system being discussed.

> **Box 13.1. Self-Splicing Is Not the Same as Mobility**
>
> - **Splicing** is the removal of an intron from precursor RNA through transesterification, releasing the intron and joining the flanking exons.
> - **Mobility** is the movement or copying of a genetic element to a new genomic site—a separate process that requires homing endonucleases, reverse transcription, recombination, or host DNA repair.
> - A self-splicing intron can be entirely non-mobile under observed conditions; absence of mobility does not reduce its catalytic significance.
> - A mobile intron can depend primarily on protein machinery (endonuclease, reverse transcriptase, repair enzymes) for movement rather than moving by RNA catalysis alone.
> - Group I introns spread mainly through homing-endonuclease-mediated cutting and repair-mediated copying; group II introns spread through retrohoming, which involves reverse splicing into DNA followed by reverse transcription.

Group II introns are better represented in the current source package and are central to RNA-linked genome innovation. A group II intron RNA folds into multiple domains that position splice sites and a branch-point adenosine. During splicing, the branch-point adenosine attacks the 5′ splice site, producing a lariat intermediate. A second transesterification ligates the exons and releases the intron lariat. This lariat chemistry is one reason group II introns are compared with spliceosomal introns.

Many group II introns encode an intron-encoded protein. The term "intron-encoded protein" should be interpreted literally: the protein-coding region lies inside the intron sequence. The protein can contribute several activities. Maturase activity helps the intron RNA fold into a catalytically competent structure. Reverse transcriptase activity copies the intron RNA into DNA during mobility. Some intron-encoded proteins also have DNA endonuclease activity or DNA-binding specificity. Not every group II intron protein has every activity, and the domain combinations vary across introns.

Retrohoming is the best-known group II intron mobility mechanism. In a simplified retrohoming cycle, the intron is transcribed as part of a precursor RNA, splices out as an RNA lariat or related intron form, and remains associated with its intron-encoded protein. The RNP recognizes a DNA target. The intron RNA reverse-splices into one strand of the DNA target. A DNA primer or nick supports reverse transcription of the intron RNA by the intron-encoded protein. DNA repair completes insertion. The outcome is a DNA locus that now contains an intron derived from an RNA intermediate.

**Table 13.2. Reverse Transcriptase Reuse Across Biology.** Diverse biological systems share RNA-templated DNA synthesis chemistry but differ in template, initiation strategy, product, and cellular role.

| System | RNA template | Primer or initiation mode | Product | Biological role | Related chapter |
| --- | --- | --- | --- | --- | --- |
| **Retrovirus** | Viral genomic RNA | tRNA annealed to primer-binding site | Proviral double-stranded DNA | Infection and integration into host genome | [Chapter 23](chapter1022.md) |
| **LINE retrotransposon** | Element mRNA | Target DNA nick (target-primed RT) | New genomic DNA insertion | Retrotransposition; genome expansion | [Chapter 16](chapter1015.md) |
| **Group II intron** | Intron RNA lariat | Reverse-spliced intron as primer in target DNA | Intron-inserted genomic DNA | Retrohoming; mobile element spread | [Chapter 27](chapter1026.md) |
| **Telomerase** | Telomerase RNA template region | Chromosome 3′ end | Telomeric repeat DNA | Chromosome-end maintenance | [Chapter 48](chapter1044.md) |
| **Retron** | Retron ncRNA (msr/msd transcript) | Internal RNA hairpin primer | Multicopy single-stranded DNA (msDNA) | Anti-phage defense; molecular recording | [Chapter 23](chapter1022.md) |
| **Diversity-generating retroelement** | Accessory template RNA | Protein-primed or nick-based initiation | Hypervariable protein-coding DNA | Diversification of surface proteins in bacteria | [Chapter 23](chapter1022.md) |
| **Defense-associated RT system** | Defense-associated noncoding RNA | ncRNA-dependent initiation | Unknown or ssDNA-linked product | Anti-phage oligomerization or defense signaling | [Chapter 13](chapter1012.md) |

This mechanism matters for evolution because group II introns join three themes that are often taught separately. They are ribozymes, because the RNA contributes directly to splicing chemistry. They are mobile elements, because some members spread between DNA sites. They are retroelements, because reverse transcription copies RNA into DNA during mobility. Retroelement-origin models of spliceosomal introns build on this convergence: group II introns and spliceosomal introns share lariat chemistry, and group II intron biology offers plausible routes from self-splicing introns to more protein-rich eukaryotic splicing systems.

The correct conclusion is not that the modern spliceosome is a slightly enlarged group II intron. The spliceosome is a complex eukaryotic RNP with small nuclear RNAs and many proteins, and eukaryotic introns have undergone extensive lineage-specific change. Modern group II introns are themselves living, evolving elements, not frozen ancestors. The strong claim is narrower and better supported: group II introns provide a mechanistic bridge among ribozyme self-splicing, lariat chemistry, intron-encoded proteins, reverse-transcriptase-linked mobility, and models for spliceosomal intron evolution.

![Figure 13.1. Mobile Ribozymes and Mobility Routes](../assets/figures/chapter1012_figure1.png)

**Figure 13.1. Mobile Ribozymes and Mobility Routes.** Group I and group II introns both show RNA catalysis inside genomes, but their dominant mobility routes differ. A group I intron can spread through endonuclease-mediated copying into an intronless allele, whereas a group II intron can move as an RNP that reverse-splices into DNA and is then copied by reverse transcriptase. Self-splicing catalysis and active mobility are distinct properties: an intron may catalyze splicing without spreading to a new site, and mobility can require protein cleavage, repair, or reverse transcription beyond the RNA reaction itself.

> **Caution**
>
> Self-splicing is not the same as mobility. A self-splicing intron may lack an active mobility route, and a mobile intron may require protein cleavage, reverse transcription, recombination, or host repair. The evidence for catalysis and the evidence for mobility should be stated separately.

## 13.2. Retrotransposons, reverse transcriptases, and RNA-mediated genome change

Retrotransposons are mobile genetic elements that move by copying an RNA intermediate into DNA. This "copy-and-paste" route differs from a simple cut-and-paste DNA transposon. In retrotransposition, a genomic element is transcribed into RNA; the RNA assembles with element-encoded or host proteins; reverse transcriptase copies the RNA into DNA; and the resulting DNA is inserted into the genome. Because the original copy usually remains, retrotransposons can increase genome size and repeat content.

![Figure 13.2. RNA-Mediated Genome Change by Retrotransposition](../assets/figures/chapter1012_figure2.png)

**Figure 13.2. RNA-Mediated Genome Change by Retrotransposition.** Retrotransposons alter genomes through a cycle of transcription, RNP assembly, reverse transcription, and insertion. In target-primed reverse transcription, the genomic target itself provides the DNA primer for copying element RNA into a new sequence, adding a copy without removing the original. Possible host consequences include disruption of coding sequence, introduction of regulatory signals, or, rarely, recruitment of element-derived material into a regulated host function.

Reverse transcriptase is the enzymatic link between RNA expression and durable DNA change. A reverse transcriptase uses RNA as a template to synthesize DNA. This chemistry is not tied to one lifestyle. Retroviruses use reverse transcriptase during infection. LTR retrotransposons use related logic without necessarily producing infectious particles. Non-LTR LINE elements use target-primed reverse transcription at genomic insertion sites. Group II introns use reverse transcriptase during retrohoming. Telomerase uses a specialized reverse transcriptase for chromosome-end extension. Retrons, diversity-generating retroelements, defense-associated systems, and biotechnology workflows use additional variations.

> **Box 13.2. Reverse Transcriptase Is a Chemistry, Not a Single Lifestyle**
>
> - Reverse transcriptase synthesizes DNA from an RNA template—one enzymatic logic shared across very different biological systems.
> - **Retroviruses** use RT to copy genomic RNA into proviral DNA during infection; the primer is a tRNA.
> - **LINE retrotransposons** use RT at the genomic insertion site; a nicked target DNA end serves as the primer (target-primed reverse transcription).
> - **Group II introns** use RT to copy intron RNA into DNA during retrohoming; the reverse-spliced intron RNA acts as the template.
> - **Telomerase** uses TERT to copy a short template region inside telomerase RNA, adding telomeric repeats at chromosome ends.
> - **Defense-associated RT systems** embed reverse-transcriptase domains in anti-phage modules where noncoding RNA may regulate enzyme activity or assembly.
> - Shared RT chemistry does not imply shared substrates, protein partners, biological products, or selection pressures; each context must be evaluated on its own evidence.

Non-LTR retrotransposons provide a mechanistic example that can be followed step by step. A LINE-like element is transcribed into RNA. The RNA is translated to produce element proteins, including proteins needed for target nicking and reverse transcription. The element RNA and proteins form an RNP. At a genomic target, an endonuclease creates a nick in DNA. The exposed DNA end acts as a primer for reverse transcription of the element RNA. The growing cDNA is joined to genomic DNA through additional reactions and repair. This process is called target-primed reverse transcription, or TPRT.

The biological consequences can be large. A new insertion can disrupt coding sequence, alter splicing, introduce a promoter or polyadenylation signal, change chromatin, recombine with another repeat, or provide new regulatory sequence. Most insertions are neutral, deleterious, silenced, or eliminated by selection. Some become useful to the host. Retroelement-derived RNAs can influence transcriptional regulation, chromatin state, RNA processing, or immune signaling. Retroelement-derived RNA in the brain has been reviewed as a source of both regulatory possibility and disease-relevant misregulation.

This creates an evidence problem. Many genomes are rich in retroelement fragments, and modern transcriptomic methods detect many repeat-overlapping RNAs. A read mapping to a retroelement family does not automatically identify which genomic copy produced the RNA. A transcript overlapping a retroelement does not prove that the retroelement sequence is functional. A correlation between retroelement expression and disease, development, or stress does not prove causality. Stronger evidence includes locus-specific mapping, independent detection of RNA ends, perturbation of the element-derived sequence, rescue, biochemical interaction, conservation of the relevant feature, and exclusion of nearby promoter or chromatin effects.

**Table 13.3. Evidence Ladder for Mobile-Element Domestication.** Ascending tiers of evidence for claiming that a mobile-element or viral-derived sequence has been recruited into a regulated host function, with what each tier leaves unproven.

| Evidence tier | What it supports | What it does not prove | Example assay or analysis | Common artifact |
| --- | --- | --- | --- | --- |
| **Genomic sequence similarity** | Shared ancestry or conserved domain | Current activity or host benefit | BLAST, RepeatMasker, domain search | Convergent fold use; horizontal transfer; neutral retention |
| **Transcription detected** | RNA production from locus | Functional RNA or regulated expression | RNA-seq, RT-PCR | Readthrough from neighboring promoter; stress-induced leakage; mapping ambiguity |
| **Chromatin marks (open chromatin, H3K4me3)** | Regulatory context of locus | Transcription or function of element-derived RNA | ChIP-seq, ATAC-seq | Chromatin state driven by adjacent gene; cell-type variation |
| **Conserved ORF or domain** | Protein-coding potential; structural conservation | In vivo protein function | Comparative genomics, dN/dS analysis | Neutral conservation by synteny; passenger retention in compact region |
| **Perturbation (knockdown, deletion)** | Contribution to observed phenotype | Causality or direct mechanism | siRNA knockdown, CRISPR deletion, antisense oligo | Off-target effects; compensation by redundant pathways |
| **Rescue (complementation)** | Specific activity of element-derived sequence | All downstream biological effects | Transgenic rescue, heterologous expression | Overexpression artifacts; compensatory pathway induction |
| **Biochemical activity** | Molecular activity in defined system | Physiological relevance at endogenous levels | Binding assay, enzymatic reconstitution in vitro or in cell | Activity only under non-physiological conditions |
| **Organismal phenotype** | Biological importance at organism level | Mechanism or molecular target | Mutant phenotype, disease association, developmental defect | Pleiotropic effects; indirect or epistatic consequence |
| **Evolutionary conservation** | Purifying selection on sequence or activity | Ancestral origin or identical function across all lineages | Multi-species alignment, structural conservation | Lineage-specific retention; horizontal transfer; compact genome constraint |

Retrotransposons also reshape the evolutionary interpretation of genomes. A host genome is not just a stable container of genes; it is a historical record of invasion, amplification, silencing, deletion, domestication, and repair. RNA is central to that record because retrotransposons pass through RNA. The RNA stage determines where transcription occurs, which proteins bind the element, whether host surveillance detects the element, whether reverse transcription can proceed, and which copies remain active. Broad mobile-element and LINE/SINE reviews support the chapter's scale claim that retrotransposons have repeatedly altered genome architecture rather than serving only as isolated mutagens. [Chapter 16](chapter1015.md) expands the classification of LINEs, SINEs, LTR retrotransposons, endogenous retroviruses, pseudogenes, and repeat-derived RNAs. This chapter emphasizes the cross-cutting principle: RNA intermediates can write new DNA history.

> **Caution**
>
> Reverse transcriptase is a chemistry, not a single biological lifestyle. A retroviral reverse transcriptase, group II intron reverse transcriptase, LINE reverse transcriptase, telomerase reverse transcriptase, and defense-associated reverse transcriptase share RNA-templated DNA synthesis logic, but their substrates, partners, products, and evolutionary pressures differ.

## 13.3. Telomerase, retroelements, and ancient RNP innovation

Telomerase is best introduced through the chromosome-end problem. Most linear chromosomes cannot be fully copied at their ends by ordinary DNA replication. If no compensating mechanism exists, terminal sequence is gradually lost. Telomerase solves this problem in many eukaryotes by extending chromosome ends with short repeated DNA sequences. The enzyme is a ribonucleoprotein. Its RNA component contains a template region, and its protein component is telomerase reverse transcriptase, usually abbreviated TERT.

The reaction can be described causally. The 3′ end of a chromosome aligns with the template region of telomerase RNA. TERT adds DNA nucleotides complementary to the RNA template. Telomerase then translocates or realigns so the template can be copied again. Repeated cycles add telomeric repeats. Proteins bound to telomeres and telomerase-associated factors regulate when and where this extension occurs. Telomerase RNA domains outside the template help assemble and position the RNP, and those domains vary substantially across eukaryotic lineages.

Telomerase belongs in this chapter because it is an RNA-templated reverse transcriptase system. The enzyme copies RNA into DNA, like retroelements do. Yet telomerase should not be described as a normal retrotransposon. Telomerase does not spread by inserting copies of itself throughout the genome. It acts at chromosome ends as a regulated host maintenance enzyme. That is why telomerase is a useful example of molecular domestication: related catalytic logic can be embedded in a host-serving RNP.

Methods shaped telomerase biology. Activity assays revealed repeat addition. Genetics connected telomere length maintenance to cellular proliferation and aging. RNA identification showed that a noncoding RNA provides the repeat template. Reconstitution and structural biology clarified which RNA and protein components are sufficient for activity and how accessory proteins stabilize the RNP. A review of methods that shaped telomerase research provides a historical and technical anchor for this evidence chain.

Recent structural work further emphasizes that telomerase is an RNP architecture, not only an active site. A human telomerase dimer structure revealed H/ACA RNP-mediated dimerization and illustrates how telomerase RNA and accessory proteins organize the enzyme beyond the reverse transcriptase domain. This structural point matters pedagogically. If telomerase is reduced to "TERT copies TER," the reader misses the fact that RNA maturation, RNA folding, RNP assembly, telomere recruitment, and regulatory proteins all shape the biological enzyme.

Evolutionary interpretation remains unsettled in detail. TERT belongs to the broader reverse-transcriptase world, and telomerase RNA creates a striking bridge between RNA template and genome maintenance. Recent telomerase RNA evolution reviews emphasize the diversity of telomerase RNA architectures across eukaryotes and the importance of treating telomerase as an evolved chromosome-maintenance RNP rather than as a simple retrotransposon derivative. The safe consensus is that telomerase uses ancient RNA-templated DNA synthesis logic in a highly regulated host RNP, not that one specific modern retroelement is the direct parent of all telomerase components.

Telomerase also illustrates why "selfish" and "host" categories are evolutionarily fluid. A reverse-transcriptase-like enzyme can be part of a mobile element in one context and part of a chromosome-maintenance machine in another. A host can silence a retroelement, tolerate a retroelement fragment, or recruit a related module. The evidence for recruitment must be mechanistic: the host system should show regulated expression, conserved activity, loss-of-function consequence, and ideally rescue or biochemical reconstitution.

![Figure 13.3. Telomerase as a Domesticated RNA-Templated RNP](../assets/figures/chapter1012_figure3.png)

**Figure 13.3. Telomerase as a Domesticated RNA-Templated RNP.** Telomerase uses an internal RNA template region to extend chromosome ends by adding short DNA repeats, solving the end-replication problem in many eukaryotes. The catalytic protein subunit TERT shares domain architecture with retroelement reverse transcriptases, yet the enzyme operates as a regulated ribonucleoprotein assembled with accessory proteins rather than as a mobile element that spreads through the genome. The same RNA-templated DNA synthesis logic that powers retroelements is thus embedded in a highly controlled chromosome-maintenance machine.

> **Caution**
>
> Telomerase is domesticated, not simply selfish. Its reverse-transcriptase chemistry is related to retroelement biology, but telomerase function is chromosome-end maintenance by a regulated host RNP.

> **Box 13.3. Telomerase Is Domesticated, Not Selfish**
>
> - Telomerase extends chromosome ends by copying a template sequence embedded within the telomerase RNA component (TR), adding tandem DNA repeats that buffer against replication-associated terminal sequence loss.
> - The catalytic subunit TERT shares reverse-transcriptase domain architecture with retroelement proteins, linking telomerase conceptually to the retroelement world.
> - Unlike a retrotransposon, telomerase does not insert copies of itself into new genomic locations; it acts only at chromosome ends and is subject to host-regulated assembly, recruitment, and activity control.
> - The full enzyme is a multi-subunit RNP: accessory proteins govern RNA maturation, RNP assembly, telomere recruitment, and regulation of repeat addition.
> - Shared chemistry links telomerase to retroelements; the evolutionary route of domestication requires direct comparative evidence beyond homology alone.

## 13.4. Viral RNA strategies as evolutionary fossils and innovations

RNA viruses use RNA in nearly every possible biological role: genome, messenger, replication intermediate, regulatory structure, packaging signal, recombination substrate, immune trigger, and sometimes template for reverse transcription. Their genome organizations vary widely. Positive-sense RNA viruses can use genomic RNA directly as mRNA. Negative-sense RNA viruses must first make complementary RNA. Double-stranded RNA viruses package and replicate RNA in specialized particles. Retroviruses carry RNA genomes but make DNA copies during infection. Segmented viruses distribute genetic information among multiple RNA molecules.

This diversity makes viral RNA biology valuable for thinking about ancient RNA possibilities. A compact RNA genome can encode proteins, fold into regulatory structures, recruit host factors, evade immune sensors, and package itself. Such features show what RNA can do under strong selection. But the word "fossil" must be used carefully. A viral RNA element may preserve an ancient biochemical strategy, resemble an ancient strategy by convergence, or represent a recent adaptation to a particular host. Direct evolutionary claims require comparative evidence, not just an appealing analogy.

Viral quasispecies provide a population-level example. RNA virus replication often has limited fidelity compared with cellular genome replication, although fidelity varies across viruses and polymerases. Mutations, selection, recombination, genetic drift, and bottlenecks generate populations of related genomes. A viral quasispecies is this mutant spectrum considered as an evolving population, not a single consensus genome. The concept helps explain immune escape, antiviral resistance, host-range shifts, and the danger of interpreting one consensus sequence as the complete viral population.

![Figure 13.4. Viral RNA Strategies: Fossil, Analogy, or Innovation?](../assets/figures/chapter1012_figure4.png)

**Figure 13.4. Viral RNA Strategies: Fossil, Analogy, or Innovation?** Viral RNA genomes contain structured elements, population diversity, and modular regulatory features that illustrate the breadth of ancient biochemical possibilities. Each feature—structured untranslated region, frameshifting signal, subgenomic RNA, endogenous viral relic in a host genome—must be classified as possible ancient retention, convergent analogy, recent host-specific adaptation, or an unresolved case requiring additional comparative and functional evidence before evolutionary claims can be drawn.

Structured viral RNA elements provide a molecular example. Viral genomes often contain structured untranslated regions, internal ribosome entry sites, frameshifting elements, packaging signals, replication promoters, long-range interactions, and local structures that influence translation or replication. In vivo structure and dynamics of the SARS-CoV-2 RNA genome demonstrated that a large viral RNA can contain structured regions and long-range interactions inside infected cells. That example does not make SARS-CoV-2 a universal model for all RNA viruses. It teaches an evidence standard: predicted base pairing is a hypothesis; structure probing, comparative conservation, mutational analysis, and infection assays are needed to connect structure to function.

Viral diversity remains undersampled. Discovery of RNA viruses among different horseshoe crab species illustrates how non-model hosts can reveal unexpected viral diversity and evolutionary history. Such sampling changes how older evolutionary claims should be read. If a viral feature appears absent from known genomes, the absence may reflect true lineage restriction, rapid divergence, host-specific adaptation, or simply insufficient sampling. The same caution applies to claims about ancient viral origins.

Endogenous viral elements add host-genome evidence. An endogenous viral element is a viral-derived sequence retained in a host genome. Endogenous retroviruses are the most familiar examples, but host genomes can contain other virus-derived fragments. Some viral relics are degraded and inactive. Some are transcribed. Some affect nearby gene regulation. Some viral proteins or regulatory sequences have been domesticated for host functions. Reviews of ancient endogenous retroviruses and viral-sequence co-option support a conservative evidence standard: genomic viral origin is only the starting point, while host-retained function requires regulated expression, phenotype, mechanism, and evolutionary persistence.

A useful example of possible retroelement-derived host regulation is the reported retroviral link to vertebrate myelination through retrotransposon-RNA-mediated control of myelin gene expression. The drafting audit marks this source as potentially relevant but not used as a core first-pass claim. The example is valuable as a reminder of the evidence standard: a domestication claim should specify the sequence source, RNA product, target genes, perturbation outcome, rescue or orthogonal evidence, and phylogenetic distribution. Without those pieces, "viral relic" remains a genomic origin label, not proof of current function.

Viral RNA strategies also influence biotechnology and therapeutics, but this chapter treats them mainly as evolutionary systems. Viral vectors, oncolytic viruses, and viral delivery methods are important later topics. Here, the main point is that viruses reveal RNA strategies under intense selection: compact coding, structured control, population diversity, rapid adaptation, and exchange with host genomes. Those features can be ancient in chemistry while modern in ecological detail.

> **Caution**
>
> Viral fossil language needs evidence. A viral RNA structure, viral polymerase strategy, or endogenous viral sequence may be ancient, convergent, recently acquired, or degraded. The claim should state which possibility is being argued and what evidence distinguishes it.

> **Box 13.4. Viral Fossil Language Needs Evidence**
>
> - A viral RNA feature may represent: (1) a **direct ancient relic** preserved by purifying selection across deeply divergent lineages; (2) a **convergent analogy** shaped independently because the same fold or strategy solves the same problem; (3) a **recent host-specific innovation** that resembles ancient chemistry without sharing its history; or (4) an **unresolved case** where current sampling, phylogenetics, or functional data cannot distinguish these possibilities.
> - Sequence similarity, structure prediction, or biochemical activity in one system cannot by itself specify the evolutionary route.
> - Claiming ancient retention requires conservation across divergent lineages, functional testing under relevant conditions, and active exclusion of convergence and horizontal transfer.
> - The undersampling of viral diversity in non-model hosts (e.g., invertebrates, environmental metagenomes) means apparent absence from known genomes is weak evidence against ancient ancestry.

## 13.5. Genome defense systems as sources of RNA-guided biotechnology

Genome defense systems evolve in conflicts among cells, viruses, plasmids, transposons, and other mobile genetic elements. They detect invaders, restrict replication, record exposure, or destroy nucleic acids. Some of the most important defense systems use RNA guides. A guide RNA is an RNA molecule whose sequence helps direct a protein or RNP to a complementary nucleic acid target. This modularity makes guide systems powerful in biology and unusually easy to adapt for biotechnology.

CRISPR-Cas immunity is the canonical example. In many bacteria and archaea, fragments of invader DNA are captured as spacers in CRISPR arrays. The array is transcribed and processed into CRISPR RNAs. A CRISPR RNA pairs with a complementary target sequence, and Cas proteins execute interference. Different CRISPR-Cas types use different effectors, targets, accessory RNAs, and processing routes, but the guiding principle is shared: nucleic acid complementarity can direct an effector to a target.

The engineering transition was dramatic because it separated programming from protein redesign. Landmark work showed RNA-guided bacterial genome editing using CRISPR-Cas systems and RNA-guided human genome engineering via Cas9. These studies did not prove that CRISPR evolved for human engineering. They showed that a natural defense mechanism could be made programmable by changing the guide RNA. That distinction is central for interpreting all defense-derived technologies.

The programmable-defense landscape is broader than Cas9. The IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases related to TnpB. TnpB-like proteins are compact compared with many Cas effectors and are associated with mobile elements, which makes them important for evolutionary interpretation and tool development. TIGR-Tas systems provide another example: modular RNA-guided DNA-targeting systems occur in prokaryotes and their viruses. These systems connect mobile elements, viral genomes, and guide-RNA logic.

![Figure 13.5. From Genome Defense to RNA-Guided Biotechnology](../assets/figures/chapter1012_figure5.png)

**Figure 13.5. From Genome Defense to RNA-Guided Biotechnology.** RNA-guided defense and mobile-element systems have provided the molecular principles for programmable genome engineering by separating a guide RNA that specifies target complementarity from an effector protein that acts on that target. CRISPR-Cas9, TnpB-like nucleases, TIGR-Tas systems, and CRISPR-associated transposons represent successive points in a landscape from natural defense or transposition toward engineered cleavage, sequence editing, and site-specific DNA insertion, with engineering utility being distinct from each system's natural biological role.

RNA-guided transposition is especially important because it changes the engineering output. A nuclease such as Cas9 can cut DNA, after which host repair determines many outcomes. A base editor or prime editor changes sequence through additional engineered modules. A CRISPR-associated transposon or RNA-guided transposon aims to insert DNA cargo at a guide-specified site. Primary CAST studies showed RNA-guided DNA insertion and transposon-encoded CRISPR-Cas-directed DNA integration, while recent review coverage frames RNA-guided genome engineering through transposons as a major shift toward programmable insertion rather than only cleavage.

Reverse transcriptase-linked defense systems expand the theme. Some bacterial anti-phage systems include reverse transcriptase modules, and at least one defense-associated reverse transcriptase system uses noncoding RNA to mediate an anti-phage oligomerization transition. This does not mean every defense-associated reverse transcriptase works like a retrotransposon. It means that reverse transcriptase domains can be embedded in defense architectures where RNA may regulate assembly, activity, or target response.

The general lesson is that genome defense converts genetic conflict into molecular innovation. Mobile elements and viruses generate pressure. Hosts evolve recognition and restriction systems. Mobile elements acquire countermeasures or co-opt defense modules. Researchers then convert some of these systems into tools. Each step changes the meaning of the molecule. A CRISPR RNA in a bacterium is an immune guide. A single-guide RNA in a laboratory genome-editing experiment is an engineered program. A transposon-associated guide RNA may have a natural role in element movement but can be redesigned for insertion technology.

> **Caution**
>
> Engineering utility is not natural function. A system can be programmable in the laboratory even if its natural role, natural targets, host range, or ecological function remains incompletely understood. Natural mechanism, evolutionary origin, and engineered use should be written as separate claims.

> **Box 13.5. Engineering Utility Is Not Natural Function**
>
> - A natural RNA-guided or RT-linked system evolves under selection for defense, mobility, replication, or host maintenance—not for programmability in a laboratory.
> - Engineering a system to cleave, edit, or insert DNA at guide-specified sites demonstrates that guide-target complementarity is mechanistically separable from the effector domain; it does not reveal what the natural system targets in its organism of origin.
> - **Natural function** (what the system does in vivo in its native context), **natural mechanism** (the biochemical steps in the cell), and **engineered use** (what researchers have made it do in a designed experiment) are three distinct propositions that require separate evidence.
> - Demonstrating programmability is a discovery about mechanistic modularity; it does not establish ecological role, natural target range, evolutionary origin, or the boundaries of safe or effective application.

**Table 13.4. RNA-Guided Biotechnology Origins.** Natural RNA-guided defense and mobile-element systems and their engineered applications, showing how guide molecule and effector are repurposed.

| Natural source | Guide molecule | Effector or machinery | Engineered output | Main engineering challenge |
| --- | --- | --- | --- | --- |
| **CRISPR-Cas9 (bacterial adaptive immunity)** | Single-guide RNA (sgRNA) | Cas9 nuclease | Double-strand break; HDR or NHEJ-mediated editing | Off-target cleavage; delivery to target tissue; PAM constraint |
| **Cas13 (bacterial RNA-targeting CRISPR)** | crRNA | Cas13 RNase | RNA knockdown; RNA base editing; nucleic acid diagnostics | Collateral cleavage of bystander RNAs; in vivo specificity |
| **TnpB (IS200/IS605 transposon endonuclease)** | Transposon-associated guide RNA (ωRNA) | TnpB compact nuclease | Compact programmable nuclease; potential base editing scaffold | Characterizing natural specificity; guide design rules; small cargo space |
| **TIGR-Tas system (prokaryotic/viral modular system)** | Modular guide RNA | TIGR-Tas effector protein | Programmable RNA-guided DNA targeting | Limited biochemical characterization; delivery constraints |
| **CRISPR-associated transposon** | crRNA or guide RNA | Transposase + Cas proteins | Site-specific DNA cargo insertion without DSB | Insertion specificity; orientation control; cargo size limits |
| **Defense-associated RT system** | Defense-associated noncoding RNA | Reverse transcriptase + defense effector | Potential RNA-recording or anti-phage tool | Early characterization stage; natural targets and mechanism incompletely known |

## Biological Contexts Across Organisms and Genetic Systems

Mobile ribozymes, retroelements, telomerase, viral RNAs, and RNA-guided defense systems are distributed unevenly across life. Their patchiness is part of their biology. A group II intron may be abundant in one bacterial lineage or organelle and absent from a close relative. A retrotransposon family may expand in a mammalian lineage but be silenced in most tissues. Telomerase is a eukaryotic chromosome-end system, but telomere biology varies across lineages. CRISPR-Cas systems are widespread in bacteria and archaea, absent from many lineages, and frequently gained or lost. RNA viruses are deeply diverse, but known diversity is biased toward sampled hosts and medically important systems.

Organelles are important contexts for mobile introns. Mitochondrial and chloroplast genomes often contain group I and group II introns, intron-encoded proteins, and maturases. These systems illustrate the boundary between genome maintenance and mobile-element activity. A maturase may be required for correct expression of an organellar gene, while the intron that encodes or recruits it may have originated as a mobile element. This creates a dependency: a host genome can become reliant on an element-derived function that was not originally host-beneficial.

Animal and plant nuclear genomes highlight retroelement consequences. Mammalian genomes contain large amounts of LINE, SINE, LTR, and endogenous retroviral sequence. Plant genomes often show large retrotransposon expansions. These repeats influence genome size, recombination, chromatin, transcription, and small-RNA pathways. [Chapter 16](chapter1015.md) covers those classes in detail. For [Chapter 13](chapter1012.md), the important point is that RNA-mediated copying has repeatedly changed genome architecture at a scale large enough to affect gene regulation and genome evolution.

Viruses and prokaryotes are major contexts for guide-RNA innovation. CRISPR-Cas systems, TnpB-like nucleases, TIGR-Tas systems, and defense-associated reverse transcriptases are discovered by comparing bacterial, archaeal, phage, plasmid, and transposon genomes. Their distribution can reflect host defense, viral counter-defense, horizontal transfer, ecological sampling, and modular recombination. A guide-RNA system may be a defense module, a mobile-element targeting module, a viral system, or a combination that resists simple categorization.

The practical rule is to state the organism and genetic system. A claim about a bacterial group II intron should not automatically be extended to plant organellar introns. A claim about human LINE-1 should not be treated as a complete model for all retrotransposons. A claim about SARS-CoV-2 RNA structure should not become a claim about all positive-sense RNA viruses. A claim about Cas9 should not be generalized to all RNA-guided defense systems.

## Technology, Computational, and Clinical Links

RNA-linked mobile and defense systems are not only evolutionary subjects. They are also sources of experimental tools. Reverse transcriptase underlies complementary DNA synthesis, reverse-transcription polymerase chain reaction, many RNA-sequencing workflows, and several genome-engineering strategies. The enzyme's usefulness comes from its ability to convert RNA information into DNA that can be amplified, sequenced, integrated, or manipulated.

Group II introns inspired mobile intron engineering strategies, and retroelements provide models for insertion, template switching, and reverse-transcription constraints. LINE-1 structural studies provide insight into target-primed reverse transcription, which is relevant for understanding mutagenesis and for thinking about engineered RNA-to-DNA writing systems. Telomerase assays and structures inform aging, cancer biology, telomere syndromes, and chromosome-end therapeutics, although those topics are handled more fully in [Chapter 48](chapter1044.md) and disease-focused chapters.

CRISPR-Cas and related systems are the clearest biotechnology link. Guide RNAs make targeting programmable by base pairing. Natural effectors have been converted into nucleases, nickases, base editors, transcriptional regulators, epigenome editors, RNA-targeting tools, diagnostics, and insertion systems. TnpB-like systems and RNA-guided transposons are attractive because they may offer compact size or programmable integration. The engineering challenges remain substantial: delivery, cargo size, guide specificity, off-target effects, repair outcomes, insertion orientation, host toxicity, immune response, and control of expression.

Computational discovery is central to this field. Many RNA-guided systems are identified by searching genomes for conserved protein domains, associated noncoding RNAs, repeats, terminal inverted repeats, transposase genes, CRISPR arrays, or defense islands. Computational prediction can nominate a system, but biochemical and cellular validation must establish guide processing, target recognition, effector activity, specificity, and biological role. This mirrors the evidence ladder from [Chapter 12](chapter1011.md): comparative signals are powerful but not sufficient alone.

Clinical interpretation requires additional caution. Retroelement activation can be associated with cancer, neurodegeneration, aging, autoimmunity, infection, or stress, but association is not causation. Viral vectors and oncolytic viruses are clinically important, but this chapter does not use them as evidence for ancient viral RNA strategies. Genome editing technologies derived from defense systems carry safety and regulatory issues that belong in later therapeutic and biotechnology chapters. Here, the clinical relevance is conceptual: systems born from genetic conflict can become sources of disease mechanisms and tools.

## Recent Consensus

- Group II introns are strong mechanistic bridges among RNA catalysis, lariat splicing, intron-encoded proteins, reverse-transcriptase-linked mobility, and models for spliceosomal intron evolution.
- Group I introns can be mobile through homing-endonuclease routes, as shown by direct group I intron mobility evidence and supported by homing-endonuclease mechanism reviews. Self-splicing and mobility remain separable properties: a group I intron can catalyze RNA splicing without every instance being mobile, and homing depends on endonuclease target recognition plus host DNA repair.
- Reverse transcriptase domains have been repeatedly repurposed in retroviruses, retrotransposons, group II introns, telomerase, retrons, defense systems, and genome-engineering tools.
- LINE-like non-LTR retrotransposons can use target-primed reverse transcription, in which a genomic DNA nick primes copying of element RNA at the insertion site.
- Telomerase is an RNA-templated reverse transcriptase RNP domesticated for chromosome-end maintenance, not an ordinary mobile element.
- RNA virus populations are often mutant spectra shaped by replication errors, selection, drift, recombination, and bottlenecks.
- Viral RNA structures can influence viral functions, but structure-function claims require evidence beyond folding prediction.
- CRISPR-Cas systems, TnpB-like systems, TIGR-Tas systems, CRISPR-associated transposons, and defense-associated reverse transcriptase modules connect genome defense, mobile elements, and RNA-guided biotechnology.
- Molecular domestication requires evidence for regulated host-retained function; sequence similarity, transcription, or genomic retention alone is insufficient.

## Open Questions, Controversies, Deprecated Models, and Common Misconceptions

Open questions:

- Which direct group I intron sources should anchor the final treatment of homing endonucleases, target recognition, and mobility routes?
- How much of spliceosomal architecture derives from group II intron ancestry, and how much reflects later eukaryotic RNP innovation?
- Which reverse transcriptase-linked defense systems are ancient, recently assembled, horizontally transferred, or repeatedly recombined from modular parts?
- How often do endogenous viral elements become regulated host functions rather than remaining silenced relics or tolerated debris?
- Which viral RNA structures are deeply conserved functional elements, and which are lineage-specific adaptations?
- Which RNA-guided transposition systems can be made specific, efficient, and predictable enough for broad genome engineering?

Common misconceptions:

- "Mobile elements are always useless genomic junk." Many mobile-element copies are neutral, harmful, or silenced, but some element-derived RNAs, proteins, promoters, splice sites, and regulatory sequences have been domesticated.
- "Self-splicing introns move by RNA catalysis alone." Splicing and mobility are distinct. Mobility often requires homing endonucleases, intron-encoded proteins, reverse transcription, recombination, or host repair.
- "Group II introns are unchanged ancestors of the spliceosome." Group II introns provide strong mechanistic clues, but spliceosomes and modern group II introns have both evolved extensively.
- "All reverse transcriptases do the same biological job." Reverse transcriptases share RNA-templated DNA synthesis but operate in different systems with different substrates, partners, products, and selection pressures.
- "Telomerase is just a retrotransposon." Telomerase uses reverse-transcriptase chemistry in a regulated host RNP for chromosome-end maintenance.
- "Viral RNA structures are automatically ancient fossils." Viral RNA structures may be ancient, convergent, host-specific, or recently evolved, and functional claims require direct evidence.
- "Engineering programmability proves natural biological purpose." A natural system can be engineered for a purpose different from its natural role. Natural function and engineered utility are separate evidence claims.

Deprecated or weakened claims:

- Deprecated or risky models:
- Treating all repeat-derived transcription as functional regulation is risky because readthrough, mapping ambiguity, stress transcription, and degradation can mimic function.
- Treating modern viruses as direct unchanged windows into the RNA world is risky because modern viruses are shaped by current hosts and immune systems.
- Treating database co-occurrence of a nuclease, guide-like RNA, and mobile element as sufficient proof of RNA-guided activity is risky without biochemical or genetic validation.